Suchergebnisse - "Buck, Steven"

PubPharm (3)

1

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro

enthalten in: Biochemical pharmacology | 2024

von Hurrish, K. | Su, Y. | Patel, S. | +26

UpdateOf: Res Sq. 2023 Apr 28;:. - PMID 37162954

2

Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia

enthalten in: Signal transduction and targeted therapy | 2020

von Luedtke, D. | Su, Y. | Ma, J. | +10

3

Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line

enthalten in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | 2012

von Vangipuram, S. | Buck, S. | Lyman, W.

1
[1]